IgG4-related Disease With Eosinophilia

Clinical trial pipeline · Data from ClinicalTrials.gov

Total trials

Actively recruiting

Phase 3 trials

Completed

Evaluation of efficacy and safety of Baricitinib combined with glucocorticoid in patients of IgG4-related disease with eosinophilia.